Cargando…
Inhibition of insulin-regulated aminopeptidase confers neuroprotection in a conscious model of ischemic stroke
Stroke is a leading cause of mortality and morbidity with a paucity of effective pharmacological treatments. We have previously identified insulin-regulated aminopeptidase (IRAP) as a potential target for the development of a new class of drugs for the treatment of stroke, as global deletion of this...
Autores principales: | Telianidis, Jonathon, Hunter, Andrew, Widdop, Robert, Kemp-Harper, Barbara, Pham, Vi, McCarthy, Claudia, Chai, Siew Yeen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643421/ https://www.ncbi.nlm.nih.gov/pubmed/37957163 http://dx.doi.org/10.1038/s41598-023-46072-5 |
Ejemplares similares
-
Editorial: Physiological, Pathological Roles and Pharmacology of Insulin Regulated Aminopeptidase
por: Chai, Siew Yeen, et al.
Publicado: (2021) -
Insulin-Regulated Aminopeptidase Inhibition Ameliorates Metabolism in Obese Zucker Rats
por: Krskova, Katarina, et al.
Publicado: (2020) -
Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase
por: Chai, Siew Yeen, et al.
Publicado: (2008) -
Insulin-regulated aminopeptidase deficiency impairs cardiovascular adaptations and placental development during pregnancy
por: Walton, Sarah L., et al.
Publicado: (2020) -
Structural Basis of Inhibition of Human Insulin-Regulated
Aminopeptidase (IRAP) by Aryl Sulfonamides
por: Vanga, Sudarsana Reddy, et al.
Publicado: (2018)